Showing results (221-230 of 267) with videos related to
Sort By:
Pageof 27
Thrombosis and Haemostasis|October 7, 2004
Thrombophilia and pregnancy complicationsBenjamin Brenner, Eric F Grabowski, Margaretta Hellgren, et al.Hemasphere|December 13, 2021
A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory LymphomaGraham P Collins, Toby A Eyre, Debora Schmitz-Rohmer, et al.Seminars in Thrombosis and Hemostasis|October 17, 2024
Venous Thromboembolism after Hospital Discharge: Temporal Trends in Baseline Characteristics, Prevention, Treatment, and 90-day OutcomesBenjamin Brenner, Inna Tzoran, Behnood Bikdeli, et al.Journal of Thrombosis and Thrombolysis|March 16, 2024
Outcomes of venous thromboembolism in patients with inherited thrombophilia treated with direct oral anticoagulants: insights from the RIETE registryOmri Cohen, Gili Kenet, Sarina Levy-Mendelovich, et al.JACC. Cardiooncology|June 17, 2026
Upper Extremity Deep Vein Thrombosis in Cancer Patients: Clinical Course by Cancer SiteOlivier Espitia, Alexis F Guedon, Emma Courouve, et al.Journal of Vascular Surgery. Venous and Lymphatic Disorders|December 1, 2019
Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica RegistryIva Golemi, Lauren Cote, Omer Iftikhar, et al.Chest|December 16, 2021
Comparison of Guidelines for Evaluation of Suspected Pulmonary Embolism in Pregnancy: A Cost-effectiveness AnalysisJohn Austin McCandlish, Chinara Feizullayeva, Alex C Spyropoulos, et al.Thrombosis and Haemostasis|April 15, 2020
Psychotropic Drugs and Outcome in Patients Receiving Anticoagulant Therapy for Venous ThromboembolismPablo Javier Marchena, Inna Tzoran, Benjamin Brenner, et al.Thrombosis and Haemostasis|May 19, 2025
Geographic and Racial Variation in Outcomes of Acute Venous Thromboembolism: Insights from the RIETE RegistryAlfonso Tafur, Benjamin Brenner, Pablo Demelo-Rodriguez, et al.Blood Advances|June 13, 2018
The endothelial tumor suppressor p53 is essential for venous thrombus formation in aged miceMagdalena L Bochenek, Tobias Bauer, Rajinikanth Gogiraju, et al.Pageof 27